AI Investment Surges in Insurance, But ROI Questions Persist

Global insurtech funding rebounded to $5.08 billion in 2025, driven significantly by a surge in artificial intelligence investments which accounted for two-thirds of the annual total. While the sector saw a 19.5% increase in capital deployment and a rise in mega-round deals, industry experts at Gallagher Re warn of a "return on investment paradox" where efficiency gains have yet to translate into clear profitability. This trend highlights a critical juncture for the insurance industry as it attempts to move beyond AI hype toward sustainable revenue generation and improved risk assessment.

According to Gallagher Re’s Q4 Global InsurTech Report, the insurtech investment landscape saw a dramatic turnaround in 2025, with annual funding reaching $5.08 billion. This recovery was fueled by a fourth-quarter surge of $1.68 billion deployed across nearly 230 AI-focused deals, marking the highest quarterly total since 2022. Property and casualty (P&C) insurtechs were primary beneficiaries, seeing a 34.9% increase in funding to $3.49 billion. This growth was supported by 11 mega-round deals, including CyberCube’s $180 million growth equity round and ICEYE’s $174.81 million Series E. Geographically, the U.S. remains the dominant hub, capturing 55.74% of global deals, with Silicon Valley-based firms nearly doubling their share of global dealmaking to 16.12%.

Despite the influx of capital, the report highlights a "return on investment paradox" where technological advancements free up employee resources without providing a clear path for utilizing that newly available capacity. Gallagher Re notes that while big tech firms invested over $1 trillion in AI infrastructure in 2025, valuations for AI companies have often outpaced their actual revenue generation, leading to concerns about a potential bubble similar to the dot-com era. The industry is currently grappling with whether AI will catalyze significant new revenue streams or merely offer incremental improvements to existing infrastructure. Consequently, the report suggests that long-term value will depend on whether AI can deliver on its more ambitious promises within the next 18 months.

Beyond financial figures, AI is fundamentally reshaping underwriting and pricing within the life, accident, and health sectors through three primary channels: biometric data, electronic health records (EHR), and genomic analysis. Insurtechs like dacadoo, HealthIQ, and Lapetus are leveraging the fact that 44% of Americans now use health-tracking wearables to provide underwriters with precise risk classifications based on sleep and heart rate data. Meanwhile, firms such as Qrvey and Human API are helping carriers interpret vast datasets from hospital EHR systems to improve product development. Most transformatively, companies like FOXO Technologies are utilizing genomic analysis to assess mortality probabilities at a molecular level, potentially shifting the industry focus from aging-related penalties toward proactive risk mitigation and behavioral change.